Reuters AbbVie said on Tuesday that it’s buying Botox-maker Allergan in a $63 billion deal. The deal could generate as much as $183 million in fees for the banks that worked on the deal, according to an estimate from Dealogic. That includes JPMorgan, which represented Allergan, Morgan Stanley, which was the lead adviser for AbbVie, […]